Caladrius Biosciences, Inc. CLBS
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 25.83M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -1.18
- Beta
- 0.91
- Short ratio
- 2.88
- Inst. own
- 19.50%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2022
- 50-d avg
- 7.53
- 200-d avg
- 9.41
- 1y target
- 4.50
MAX chart
Chart tools
Chart is warming up
The all-time price history for CLBS has not been loaded yet. Try again in a moment.
Altman Z-Score
-71.10 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.2×
P/S 21.8×
P/B 0.2×
P/FCF -0.2×
EV/EBITDA 0.0×
EV/Sales -72.1×
FCF Yield -431.3%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin -9756.5%
ROE -111.7%
ROIC 0.0%
ROA -93.5%
Revenue -83.0%
Operating Income 0.0%
EPS (diluted) 20.4%
Free Cash Flow 17.5%
Current Ratio 5.8×
Quick Ratio 5.8×
Debt / Equity 0.0×
Net Debt / EBITDA 0.0×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31